부산대학교 도서관

Simões, Bruno M; O'Brien, Ciara S; Eyre, Rachel; Silva, Andreia; Yu, Ling; Sarmiento-Castro, Aida; Alférez, Denis G; Spence, Kath; Santiago-Gómez, Angélica; Chemi, Francesca; Acar, Ahmet; Gandhi, Ashu; Howell, Anthony; Brennan, Keith; Rydén, Lisa; Catalano, Stefania; Andó, Sebastiano; Gee, Julia; Ucar, Ahmet; Sims, Andrew H; Marangoni, Elisabetta; Farnie, Gillian; Landberg, Göran; Howell, Sacha J; Clarke, Robert B

Cell Reports. 12(12):1968-1977

Eyre, Rachel; Alférez, Denis G; Spence, Katherine; Kamal, Mohamed; Shaw, Frances L; Simões, Bruno M; Santiago-Gómez, Angélica; Sarmiento-Castro, Aida; Bramley, Maria; Absar, Mohammed; Saad, Zahida; Chatterjee, Sumohan; Kirwan, Cliona; Gandhi, Ashu; Armstrong, Anne C; Wardley, Andrew M; O'Brien, Ciara S; Farnie, Gillian; Howell, Sacha J; Clarke, Robert B

J Mammary Gland Biol Neoplasia
Eyre, R, Alférez, D G, Spence, K, Kamal, M, Shaw, F L, Simões, B M, Santiago-Gómez, A, Sarmiento-Castro, A, Bramley, M, Absar, M, Saad, Z, Chatterjee, S, Kirwan, C, Gandhi, A, Armstrong, A C, Wardley, A M, O'Brien, C S, Farnie, G, Howell, S J & Clarke, R B 2016, 'Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis', Journal of Mammary Gland Biology and Neoplasia. https://doi.org/10.1007/s10911-016-9361-8

Simões, Bruno M; Santiago-Gómez, Angélica; Chiodo, Chiara; Moreira, Tiago; Conole, Daniel; Lovell, Scott; Alférez, Denis G; Eyre, Rachel; Spence, Katherine; Sarmiento-Castro, Aida; Kohler, Bertram; Morisset, Ludivine; Lanzino, Marilena; Andó, Sebastiano; Marangoni, Elisabetta; Sims, Andrew; Tate, Edward W; Howell, Sacha J; Clarke, Robert B.

Simões, B M, Santiago-Gómez, A, Chiodo, C, Moreira, T, Conole, D, Lovell, S, Alférez, D G, Eyre, R, Spence, K, Sarmiento-Castro, A, Kohler, B, Morisset, L, Lanzino, M, Andó, S, Marangoni, E, Sims, A, Tate, E W, Howell, S J & Clarke, R B 2020, ' Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer : Targeting STAT3 in endocrine resistant breast cancer ', Oncogene . https://doi.org/10.1038/s41388-020-1335-z

Eyre, Rachel; Alférez, Denis G; Santiago-Gómez, Angélica; Spence, Kath; McConnell, James C; Hart, Claire; Simões, Bruno M; Tulotta, Claudia; Storer, Joanna; Gurney, Austin; Clarke, Noel; Brown, Michael D; Howell, Sacha J; Sims, Andrew; Farnie, Gillian; Ottewell, Penelope D; B. Clarke, Robert

Eyre, R, Alférez, D G, Santiago-Gómez, A, Spence, K, McConnell, J C, Hart, C, Simões, B M, Tulotta, C, Storer, J, Gurney, A, Clarke, N, Brown, M D, Howell, S J, Sims, A, Farnie, G, Ottewell, P D & B. Clarke, R 2019, ' Microenvironmental IL1 1 β promotes metastatic colonisation of breast cancer cells in the bone via activation of Wnt-dependent cancer stem cell activity ', Nature Communications . https://doi.org/10.1038/s41467-019-12807-0

Chen F; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Gurler SB; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Novo D; Wellcome Trust Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Selli C; Applied Bioinformatics of Cancer, Institute of Genetics and Cancer, University of Edinburgh Cancer Research Centre, Edinburgh, UK.; Alferez DG; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Eroglu S; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Pavlou K; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Zhang J; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Sims AH; Applied Bioinformatics of Cancer, Institute of Genetics and Cancer, University of Edinburgh Cancer Research Centre, Edinburgh, UK.; Humphreys NE; Genome Editing Unit, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Adamson A; Genome Editing Unit, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Campbell A; Cancer Research UK Beatson Institute, Glasgow, UK.; Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Tournier C; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Clarke RB; Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Brennan K; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Streuli CH; Wellcome Trust Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Ucar A; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. ahmet.ucar@manchester.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Dobrolecki LE; The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.; Airhart SD; The Jackson Laboratory, Bar Harbor, ME, 04609, USA.; Alferez DG; Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.; Aparicio S; Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 W10th Avenue, Vancouver, V6R 3A6, Canada.; Behbod F; Department of Pathology, University of Kansas Medical Center, |3901 Rainbow Blvd, WHE 1005B, Kansas City, KS, 66160, USA.; Bentires-Alj M; Department of Biomedicine, University of Basel, University Hospital Basel, Lab 306, Hebelstrasse 20, CH-4031, Basel, Switzerland.; Brisken C; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.; Bult CJ; The Jackson Laboratory, Bar Harbor, ME, 04609, USA.; Cai S; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Clarke RB; Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.; Dowst H; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.; Ellis MJ; The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.; Gonzalez-Suarez E; Cancer Epigenetics and Biology Program, PEBC, Bellvitge Institute for Biomedical Research, IDIBELL, Av. Gran Via de L'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Iggo RD; INSERM U1218, Bergonié Cancer Institute, 229 cours de l'Argonne, 33076, Bordeaux, France.; Kabos P; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.; Li S; Department of Internal Medicine, Washington University, St. Louis, MO, 63130, USA.; Lindeman GJ; Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.; Department of Medicine, The University of Melbourne, Parkville, VIC, 3010, Australia.; Familial Cancer Centre, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Grattan St, Parkville, VIC, 3050, Australia.; Marangoni E; Translational Research Department, Institut Curie, 26, rue d'Ulm, 75005, Paris, France.; McCoy A; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Meric-Bernstam F; Departments of Investigational Cancer Therapeutics and Breast Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 77030, USA.; Piwnica-Worms H; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Poupon MF; Founder and Scientific Advisor, XenTech SA, Genopole, 4 rue Pierre Fontaine, 91000, Evry, France.; Reis-Filho J; Director of Experimental Pathology, Department of Pathology, Affiliate Member, Human Oncology and Pathogenesis Program, and Center for Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Sartorius CA; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.; Scabia V; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.; Sflomos G; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.; Tu Y; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Vaillant F; Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia.; Visvader JE; Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia.; Welm A; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.; Wicha MS; Madeline and Sidney Forbes Professor of Oncology, Director, Forbes Institute for Cancer Discovery, NCRC 26-335S, SPC 2800 2800 Plymouth Rd, Ann Arbor, MI, 48109-2800, USA.; Lewis MT; The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA. mtlewis@bcm.edu.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Print Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

Eyre R; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Alférez DG; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Spence K; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Kamal M; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Department of Zoology, Faculty of Science, University of Benha, Benha, Egypt.; Shaw FL; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Simões BM; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Santiago-Gómez A; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Sarmiento-Castro A; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Bramley M; Pennine Acute Hospitals NHS Trust, Manchester, UK.; Absar M; Pennine Acute Hospitals NHS Trust, Manchester, UK.; Saad Z; Salford Royal NHS Foundation Trust, Manchester, UK.; Chatterjee S; Salford Royal NHS Foundation Trust, Manchester, UK.; Kirwan C; University Hospitals of South Manchester NHS Foundation Trust, Manchester, UK.; Gandhi A; University Hospitals of South Manchester NHS Foundation Trust, Manchester, UK.; Armstrong AC; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; Wardley AM; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; O'Brien CS; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; Farnie G; Cancer Stem Cell Research, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Howell SJ; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK.; Clarke RB; Breast Biology Group, Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer, Research Centre, University of Manchester, Wilmslow Road, Manchester, M20 4QL, UK. robert.clarke@manchester.ac.uk.

Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 9601804 Publication Model: Print Cited Medium: Internet ISSN: 1573-7039 (Electronic) Linking ISSN: 10833021 NLM ISO Abbreviation: J Mammary Gland Biol Neoplasia Subsets: PubMed not MEDLINE

Alferez, Denis G; Ryan, Anderson J; Goodlad, Robert A; Wright, Nick A; Wilkinson, Robert W

Alferez, D G, Ryan, A J, Goodlad, R A, Wright, N A & Wilkinson, R W 2010, ' Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model ', International Journal of Oncology, vol. 37, no. 4, pp. 767-72 .

Alferez DG; Breast Biology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4GJ UK.; Simões BM; Breast Biology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4GJ UK.; Howell SJ; Breast Biology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4GJ UK.; Department of Medical Oncology, The University of Manchester, The Christie NHS Foundation Trust, Manchester, M20 4BX UK.; Clarke RB; Breast Biology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4GJ UK.

Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101650643 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-7866 (Print) NLM ISO Abbreviation: Curr Stem Cell Rep Subsets: PubMed not MEDLINE

Byrne AT; Alférez DG; Amant F; Annibali D; Arribas J; Biankin AV; Bruna A; Budinská E; Caldas C; Chang DK; Clarke RB; Clevers H; Coukos G; Dangles-Marie V; Eckhardt SG; Gonzalez-Suarez E; Hermans E; Hidalgo M; Jarzabek MA; de Jong S; Jonkers J; Kemper K; Lanfrancone L; Mælandsmo GM; Marangoni E; Marine JC; Medico E; Norum JH; Palmer HG; Peeper DS; Pelicci PG; Piris-Gimenez A; Roman-Roman S; Rueda OM; Seoane J; Serra V; Soucek L; Vanhecke D; Villanueva A; Vinolo E; Bertotti A; Trusolino L

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer

Byrne AT; EurOPDX Consortium and are at the Royal College of Surgeons in Ireland, Dublin 2, Ireland.; Alférez DG; EurOPDX Consortium and are at the Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester M20 4QL, UK.; Amant F; EurOPDX Consortium and are at the Katholieke Universiteit Leuven, 3000 Leuven, Belgium.; The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.; Annibali D; EurOPDX Consortium and are at the Katholieke Universiteit Leuven, 3000 Leuven, Belgium.; Arribas J; EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology, 08035 Barcelona, the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; CIBERONC, 08035 Barcelona, Spain.; Biankin AV; EurOPDX Consortium and are at the Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.; Bruna A; EurOPDX Consortium and are at Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge CB2 0RE, UK.; Budinská E; EurOPDX Consortium and is at the Institute of Biostatistics and Analyses, Faculty of Medicine, and Research Centre for Toxic Compounds in the Environment, Faculty of Science, Masarykova Univerzita, 625 00 Brno, Czech Republic.; Caldas C; EurOPDX Consortium and are at Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge CB2 0RE, UK.; Chang DK; EurOPDX Consortium and are at the Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.; Clarke RB; EurOPDX Consortium and are at the Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester M20 4QL, UK.; Clevers H; Hubrecht Institute, University Medical Centre Utrecht, and Princess Maxima Center for Pediatric Oncology, 3584CT Utrecht, The Netherlands.; Coukos G; EurOPDX Consortium and are at Lausanne Branch, Ludwig Institute for Cancer Research at the University of Lausanne, 1066 Lausanne, Switzerland.; Dangles-Marie V; EurOPDX Consortium and is at the Institut Curie, PSL Research University, Translational Research Department, 75005 Paris, and Université Paris Descartes, Sorbonne Paris Cité, Faculté de Pharmacie de Paris, 75006 Paris, France.; Eckhardt SG; University of Colorado Cancer Center, Aurora, Colorado 80045, USA.; Gonzalez-Suarez E; EurOPDX Consortium and is at the Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute IDIBELL, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Hermans E; EurOPDX Consortium and are at the Katholieke Universiteit Leuven, 3000 Leuven, Belgium.; Hidalgo M; EurOPDX Consortium and is at Beth Israel Deaconess Medical Center, Boston, Harvard Medical School, Boston, Massachusetts 02215, USA.; Jarzabek MA; EurOPDX Consortium and are at the Royal College of Surgeons in Ireland, Dublin 2, Ireland.; de Jong S; EurOPDX Consortium and is at the University Medical Centre Groningen, University of Groningen, 9713GZ Groningen, The Netherlands.; Jonkers J; EurOPDX Consortium and are at The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.; Kemper K; EurOPDX Consortium and are at The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.; Lanfrancone L; EurOPDX Consortium and are at the Department of Experimental Oncology, European Institiute of Oncology, 20139 Milan, Italy.; Mælandsmo GM; EurOPDX Consortium and are at Oslo University Hospital, Institute for Cancer Research, 0424 Oslo, Norway.; Marangoni E; EurOPDX Consortium and are at Institut Curie, PSL Research University, Translational Research Department, 75005 Paris, France.; Marine JC; EurOPDX Consortium and is at the Laboratory for Molecular Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, and the Center for Cancer Biology, VIB, 3000 Leuven, Belgium.; Medico E; EurOPDX Consortium and are at the Candiolo Cancer Institute IRCCS and Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Norum JH; EurOPDX Consortium and are at Oslo University Hospital, Institute for Cancer Research, 0424 Oslo, Norway.; Palmer HG; EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology and CIBERONC, 08035 Barcelona, Spain.; Peeper DS; EurOPDX Consortium and are at The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.; Pelicci PG; EurOPDX Consortium and are at the Department of Experimental Oncology, European Institiute of Oncology, 20139 Milan, Italy.; Piris-Gimenez A; EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology and CIBERONC, 08035 Barcelona, Spain.; Roman-Roman S; EurOPDX Consortium and are at Institut Curie, PSL Research University, Translational Research Department, 75005 Paris, France.; Rueda OM; EurOPDX Consortium and are at Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge CB2 0RE, UK.; Seoane J; EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology, 08035 Barcelona, the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; CIBERONC, 08035 Barcelona, Spain.; Serra V; EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology and CIBERONC, 08035 Barcelona, Spain.; Soucek L; EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology, 08035 Barcelona, the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; Vanhecke D; EurOPDX Consortium and are at Lausanne Branch, Ludwig Institute for Cancer Research at the University of Lausanne, 1066 Lausanne, Switzerland.; Villanueva A; EurOPDX Consortium and is at the Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology ICO, Bellvitge Biomedical Research Institute IDIBELL, 08098 L'Hospitalet de Llobregat, Barcelona, and Xenopat S.L., Business Bioincubator, Bellvitge Health Science Campus, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Vinolo E; Seeding Science SAS, 75020 Paris, France.; Bertotti A; EurOPDX Consortium and are at the Candiolo Cancer Institute IRCCS and Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Trusolino L; EurOPDX Consortium and are at the Candiolo Cancer Institute IRCCS and Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE

Simões BM; Breast Biology GroupBreast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Wilmslow Road, Manchester M20 4BX, UKDepartment of Medical OncologyThe Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK Bruno.Simoes@ics.manchester.ac.uk.; Alferez DG; Breast Biology GroupBreast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Wilmslow Road, Manchester M20 4BX, UKDepartment of Medical OncologyThe Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.; Howell SJ; Breast Biology GroupBreast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Wilmslow Road, Manchester M20 4BX, UKDepartment of Medical OncologyThe Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK Breast Biology GroupBreast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Wilmslow Road, Manchester M20 4BX, UKDepartment of Medical OncologyThe Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.; Clarke RB; Breast Biology GroupBreast Cancer Now Research Unit, Institute of Cancer Sciences, University of Manchester, Wilmslow Road, Manchester M20 4BX, UKDepartment of Medical OncologyThe Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.

Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE

Alferez DG; Histopathology Unit, London Research Institute, Cancer Research UK, Lincoln's Inn Fields, London, UK.; Goodlad RA; Odedra R; Sini P; Crafter C; Ryan AJ; Wedge SR; Wright NA; Anderson E; Wilkinson RW

Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE